Dr. Slaoui said data shows a half dose of Moderna’s COVID-19 vaccine induces an “identical immune response” to the recommended full 100 microgram dose for people ages 18 to 55.
He also said the federal government is in discussions with Moderna and with the FDA to start administering half doses of Moderna’s vaccine; that decision is ultimately up to the FDA.
More articles on pharmacy:
West Virginia clinic gives 42 patients antibody cocktail instead of COVID-19 vaccine
Pfizer vs. Moderna COVID-19 vaccine: What’s the same & what’s different
Operation Warp Speed chief on vaccine distribution: ‘We know that it should be better’
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.